| pubmed-article:831965 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:831965 | lifeskim:mentions | umls-concept:C0037369 | lld:lifeskim |
| pubmed-article:831965 | lifeskim:mentions | umls-concept:C0027051 | lld:lifeskim |
| pubmed-article:831965 | lifeskim:mentions | umls-concept:C0040038 | lld:lifeskim |
| pubmed-article:831965 | lifeskim:mentions | umls-concept:C0019134 | lld:lifeskim |
| pubmed-article:831965 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:831965 | lifeskim:mentions | umls-concept:C1292733 | lld:lifeskim |
| pubmed-article:831965 | pubmed:issue | 6052 | lld:pubmed |
| pubmed-article:831965 | pubmed:dateCreated | 1977-3-15 | lld:pubmed |
| pubmed-article:831965 | pubmed:abstractText | A trial of low-dose subcutaneous heparin to prevent thromboembolic complications after myocardial infarction was carried out in 78 patients. Of the 37 heparin-treated patients only two (5%) developed evidence of leg vein thrombosis, while 14 (34%) of the 41 controls did so, and five controls developed pulmonary emboli. Leg vein thrombosis developed in 12 (50%) of the 24 controls who did not smoke cigarettes but in only two (13%) of the 17 controls who were cigarette smokers. Non-smokers who have a myocardial infarction should be given low-dose heparin subcutaneously to prevent leg vein thrombosis and pulmonary embolism. | lld:pubmed |
| pubmed-article:831965 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:831965 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:831965 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:831965 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:831965 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:831965 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:831965 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:831965 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:831965 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:831965 | pubmed:language | eng | lld:pubmed |
| pubmed-article:831965 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:831965 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:831965 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:831965 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:831965 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:831965 | pubmed:issn | 0007-1447 | lld:pubmed |
| pubmed-article:831965 | pubmed:author | pubmed-author:MarksPP | lld:pubmed |
| pubmed-article:831965 | pubmed:author | pubmed-author:EmersonP APA | lld:pubmed |
| pubmed-article:831965 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:831965 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:831965 | pubmed:volume | 1 | lld:pubmed |
| pubmed-article:831965 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:831965 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:831965 | pubmed:pagination | 18-20 | lld:pubmed |
| pubmed-article:831965 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:831965 | pubmed:meshHeading | pubmed-meshheading:831965-H... | lld:pubmed |
| pubmed-article:831965 | pubmed:meshHeading | pubmed-meshheading:831965-S... | lld:pubmed |
| pubmed-article:831965 | pubmed:meshHeading | pubmed-meshheading:831965-P... | lld:pubmed |
| pubmed-article:831965 | pubmed:meshHeading | pubmed-meshheading:831965-T... | lld:pubmed |
| pubmed-article:831965 | pubmed:meshHeading | pubmed-meshheading:831965-A... | lld:pubmed |
| pubmed-article:831965 | pubmed:meshHeading | pubmed-meshheading:831965-H... | lld:pubmed |
| pubmed-article:831965 | pubmed:meshHeading | pubmed-meshheading:831965-F... | lld:pubmed |
| pubmed-article:831965 | pubmed:meshHeading | pubmed-meshheading:831965-M... | lld:pubmed |
| pubmed-article:831965 | pubmed:meshHeading | pubmed-meshheading:831965-T... | lld:pubmed |
| pubmed-article:831965 | pubmed:meshHeading | pubmed-meshheading:831965-M... | lld:pubmed |
| pubmed-article:831965 | pubmed:meshHeading | pubmed-meshheading:831965-M... | lld:pubmed |
| pubmed-article:831965 | pubmed:year | 1977 | lld:pubmed |
| pubmed-article:831965 | pubmed:articleTitle | Preventing thromboembolism after myocardial infarction: effect of low-dose heparin or smoking. | lld:pubmed |
| pubmed-article:831965 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:831965 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:831965 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:831965 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:831965 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:831965 | lld:pubmed |
